The short answer: In chronic kidney disease (CKD), statins and fibrates serve different purposes. Statins are primarily used to reduce cardiovascular risk and are generally the foundation of lipid treatment for appropriate patients with CKD. Fibrates are more effective at lowering triglycerides, but their use becomes more complicated as kidney function declines because they can … Read more
The short answer: Statins are generally an important part of cardiovascular risk management for many people with moderate to severe chronic kidney disease (CKD). Having CKD does not automatically make statins unsafe or mean they will damage the kidneys. The important distinction is that statins are used mainly to reduce cardiovascular risk, not to directly … Read more
The short answer Proton pump inhibitors (PPIs) can cause acute interstitial nephritis (AIN), a form of inflammatory kidney injury, but this is an uncommon complication. It does not mean that everyone taking a PPI will develop kidney disease. Common PPIs include omeprazole, pantoprazole, esomeprazole, lansoprazole, and rabeprazole. They reduce stomach acid and are widely used … Read more
The short answer Chronic kidney disease (CKD) can change how long certain antibiotics remain in the body. When the kidneys clear a drug more slowly, the same dose may produce higher or more prolonged drug exposure. This is particularly important with aminoglycosides such as gentamicin and amikacin and with vancomycin, because excessive exposure can increase … Read more
The short answer Modern contrast dye does not automatically damage the kidneys. The risk depends strongly on the type of contrast, how it is given, your kidney function, and your overall medical condition. There is also an important terminology issue. A rise in creatinine after contrast is often called contrast-associated acute kidney injury (CA-AKI), but … Read more
The short answer Diuretics (“water pills”) help the kidneys remove excess sodium and water through urine. They are commonly used in CKD when fluid retention causes swelling (edema), weight gain, high blood pressure, or shortness of breath from fluid overload. The choice between a loop diuretic and a thiazide or thiazide-like diuretic depends on the … Read more
The short answer Finerenone (Kerendia) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) used to reduce the risk of kidney and cardiovascular complications in certain adults with type 2 diabetes and chronic kidney disease (CKD). It is not simply a blood-pressure drug. Finerenone blocks the mineralocorticoid receptor, which can become overactive in diabetes and contribute to … Read more
The short answer Farxiga (dapagliflozin) and Jardiance (empagliflozin) belong to a class of medicines called SGLT2 inhibitors. They were originally developed as diabetes medicines, but their benefits extend beyond lowering blood sugar. In appropriate people with chronic kidney disease (CKD), SGLT2 inhibitors can slow the loss of kidney function and reduce the risk of kidney … Read more
The short answer Lisinopril is an ACE inhibitor, while losartan is an angiotensin II receptor blocker (ARB). Both block the renin-angiotensin system, which helps regulate blood pressure and pressure inside the kidney’s filtering units, called glomeruli. In people with CKD—particularly those with albuminuria (excess albumin in the urine)—ACE inhibitors and ARBs can reduce pressure within … Read more
The short answer If you have chronic kidney disease (CKD), the main over-the-counter pain relievers to be cautious about are NSAIDs (nonsteroidal anti-inflammatory drugs), including ibuprofen, naproxen, and high-dose aspirin. These medicines can reduce blood flow through the kidneys and may trigger acute kidney injury (AKI) or worsen existing CKD, particularly with higher doses, repeated … Read more